Epilepsy is a chronic brain disorder affecting both children and adults. Its prevalence is approximately 8 to 9 cases per 1000 persons. Out of 100 children under the age of 15, five have experienced at least one epileptic seizure [1]. In approximately 30% of children with epilepsy, the response to conventional antiseizure medication (ASM) is insufficient [2]. A rational approach is crucial in the pharmacotherapy of epilepsy. If monotherapy is insufficient in controlling seizures, alternative monotherapy may be attempted, or combination therapy with additional antiseizure medications (ASMs) is considered.
1
SEP
SEP
0